ArticleBMC immunology2018

Therapeutic cancer vaccine: phase I clinical tolerance study of Hu-rhEGF-rP64k/Mont in patients with newly diagnosed advanced non-small cell lung cancer.

Puyuan Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.